Sweet and blind spots in E3 ligase ligand space revealed by a thermophoresis-based assay

December 4, 2020

Maiwald, S., Heim, C., Alvarez, B., et al.

ACS Medicinal Chemistry Letters 2020, doi: 10.1021/acsmedchemlett.0c00440

Abstract

Repurposing E3 ubiquitin ligases for targeted protein degradation via customized molecular glues or proteolysis-targeting chimeras (PROTACs) is an increasingly important therapeutic modality. Currently, a major limitation in the design of suitable molecular glues and PROTACs is our fragmentary understanding of E3 ligases and their ligand space. We here describe a quantitative assay for the discovery and characterization of E3 ligase ligands that is based on the thermophoretic behavior of a custom reporter ligand. Thereby, it is orthogonal to commonly employed fluorescence-based assays and less affected by the optical properties of test compounds. It can be employed for the high-throughput screening of compound libraries for a given ligase but also for hit validation, which we demonstrate with the identification of unexpected well-binders and non-binders, yielding new insights into the ligand space of cereblon (CRBN).

View Publication

Topics: Monolith, MST, PROTACs, Publications

Previous Article
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody

Up next
Lipids activate SecA for high affinity binding to the SecYEG complex
Lipids activate SecA for high affinity binding to the SecYEG complex

Ready to characterize your most challenging interactions?

Discover tools to measure binding affinity

Learn more